Emerging treatments and gene expression profiling in high-risk medulloblastoma.

Abstract excerpt

The past decades have seen an increase in the survival rates of patients with standard-risk medulloblastoma. Efforts have, therefore, been focused on obtaining better results in the treatment of patients with high-risk tumors. In addition to consolidated therapies, novel approaches such as small...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antibodies, Monoclonal
• Share to Angiogenesis Inhibitors
• Share to Cerebellar Neoplasms